BioTechniques is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Journal
    • Aims and scope
    • Journal archive
    • Editorial board
    • For authors
    • Your editors: what do we do?

    Follow us on social media

  • Current issue
  • News
    • Latest news
    • Tech news
    • Events news
    • Company news

    Follow us on social media

  • Multimedia
    • Downloadable eBooks
    • Infographics
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • Features
    • Interviews
    • Opinion
    • In Focus
    • Spotlights
    • Companies
    • New products
    • Events

    Follow us on social media

  • Topics
    • Analytical chemistry
      • Biochemistry
      • Bioengineering and biophysics
      • Cancer research
      • Careers and Publishing
      • Cell and tissue biology
      • COVID-19
      • CRISPR
      • Computational biology
    • Diagnostics and preclinical
      • Drug discovery and development
      • Immunology
      • Lab design and machinery
      • Microbiology
      • Molecular biology
    • Nanomedicine
      • Neuroscience
      • PCR and sequencing
      • Plant and climate science
      • Proteomics
      • Veterinary science
      • Whole-genome studies

    Follow us on social media

  • Become a member
Our new In Focus on organ-on-a-chip technology is live! CHECK IT OUT

eBook: Antibody discovery

19 Jul 2023
Written by Annie Coulson (Digital Editor)
Drug discovery and development Immunology

This eBook rounds up key features from our Spotlight on antibody discovery, including the various techniques and technologies utilized in antibody discovery, how high-throughput flow cytometry can be used for successful discovery campaigns and the emerging role of artificial intelligence in antibody discovery.

Top content

  • GelGenie: magicking gel electrophoresis analysis into the 21st century
  • Pick of the posters: AACR 2025
  • First disease-specific markers for frontotemporal dementia

Related tags

antibody discovery
Previous article Next article

Related articles

17 MAR 2023 DRUG DISCOVERY AND DEVELOPMENT

Utilizing advanced high-throughput flow cytometry to quantify direct and competitive live cell antibody binding

17 MAR 2023 DRUG DISCOVERY AND DEVELOPMENT

Survey: Antibody discovery

phage display
24 APR 2023 DRUG DISCOVERY AND DEVELOPMENT

Developing immunodiagnostics to tackle antimicrobial resistance

17 MAR 2023 ANALYTICAL CHEMISTRY

Evaluation of complement-dependent cytotoxicity using a streamlined, miniaturized advanced flow cytometry assay

10 MAY 2023 DRUG DISCOVERY AND DEVELOPMENT

eBook: Antibody discovery, validation and process optimization

streptococcal
28 MAR 2023 IMMUNOLOGY

Hostess with the mostest: studying host–pathogen interactions

  • About BioTechniques
  • Advisory Board
  • Contact Us
  • Advertising
  • Permissions
  • Whitelist Emails
Contact
Contact Us
Office info

BioTechniques is powered by Taylor & Francis Group

BioTechniques, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom

Impact Factor 2.2 | CiteScore 2.0

  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 BioTechniques